Physiological significance of human placental aminopeptidases
Physiological significance of human placental aminopeptidases
批准号:
05454444
负责人:
MIZUTANI Shigehiko
金额:
$3.97万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1995
中文摘要
我们试图通过生物活性多肽激素与其在胎盘中的降解酶之间的相互关系来了解妊娠的病理生理学。基础研究:(1)从人胎盘c DNA文库中克隆了编码P-LAP的全长4084个碱基对的c DNA克隆。(2)人胎盘中的催产素和加压素降解酶为P-LAP。(3)人胎盘中的生长抑素降解酶为P-LAP。P-LAP可能不仅通过调节胎儿胎盘循环中生长抑素的浓度,而且还通过调节血管活性多肽,如血管加压素,参与胎儿-胎盘循环的发育。(4)人胎盘中血管紧张素II降解的起始酶-氨基转移酶A和氨基转移酶N(AP-N)。(5)胎盘氨基转移酶A和氨基转移酶N(AP-N)降解免疫调节肽。胸腺五肽和脾五肽。结论:1.AP-N可能通过调节免疫调节肽的浓度参与妊娠免疫。临床研究发现:(1)孕期血清中可降解缓激肽的氨基磷脂酶P随着孕周的延长而升高,(2)P-LAP对过期妊娠和早产的监测有一定价值。(3)正常妊娠组的脉冲多普勒S/D比值与P-LAP活性呈显著正相关。妊娠血清中P-LAP活性可能通过调节胎儿血管加压素浓度来反映脐动脉的血管阻力。
英文摘要
We tried to understand pathophysiology in pregnancy via interrelationship between bioactive peptide hormones and their degradation proteases in placenta.1. Basic Research We showed the following evidences :(1) We isolated a cDNA clone with 4084 base pairs encoding P-LAP from a human placental cDNA library. The deduced suquence contains a hydrophobic region near the N terminus, suggesting that the enzyme is a type II intergral membrane protein.(2) The oxytocin and vasopressin degradation protease in human placenta is P-LAP.(3) The somatostatin degradation protease in human placenta is P-LAP.P-LAP might be involved in the development of the fetus via regulation not only the concentration of somatostatin but also vasoactive peptides such as vasopressin in the feto-placental circulation.(4) The initiating protease of angiotensin II degradation in human placental in aminopeptidase A and aminopeptidase N (AP-N).(5) Placental AP-N (CD13) degrades immunomodulating peptides such as tuftsin, thymopentin and splenopentin. AP-N might be involved in the immunology of pregnancy via regulating the concentration of immunomodulating peptides.2. Clinical Research We showed the following evidences :(1) Aminopepidase P,which might degrade bradykinin, increases in pregnancy sera with advancing gestation.(2) P-LAP in useful for monitoring post date pregnancy and premature delivery.(3) We found the significant correlation between pulsed Doppler S/D ratio and P-LAP activity in normal pregnancy. The P-LAP activity in pregnancy sera might reflect the vascular resistance in umbilical artery via regulation the concentration of fetal vasopression.
期刊论文(174)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
八神博史: "Catheter-tip transducerを使った卵膜外子宮内圧測定法." 日産婦誌. 45. 1399-1403 (1993)
Hiroshi Yagami:“使用导管尖端传感器的鞘外子宫内压力测量方法。”Nissan Gynecology 45. 1399-1403 (1993)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T.Rogi: "Human placental leucine aminopeptidase/Oxytocinase A new member of type II membrane-spanning zinc metalloptidase family" J.Biol.Chem.271. 56-61 (1996)
T.Rogi:“人胎盘亮氨酸氨肽酶/催产素酶是 II 型跨膜锌金属优化酶家族的新成员”J.Biol.Chem.271。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
水谷栄彦: "産婦人科Clinical Data胎盤酵素" 産と婦 増刊号. 14-16 (1993)
Eihiko Mizutani:“妇产科临床数据胎盘酶”妇产科和妇女特刊 14-16 (1993)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H.Yagami: "Expression of angiotensin converting enzyme in human placenta and its physiologic role in the fetal circulation." Obstet.Gynecol.84. 453-457 (1994)
H.Yagami:“血管紧张素转换酶在人胎盘中的表达及其在胎儿循环中的生理作用。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
S.Mizutani: "Changes of aminopeptidase P activity in normal pregnancy." Med.Sci.Res.22. 83-95 (1994)
S.Mizutani:“正常妊娠时氨肽酶 P 活性的变化。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 54 条
Physiological roles of placental leucine aminopeptidase/oxytocinase and its clinical application using molecular biological technique.
-
批准号:12470341
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$5.5万
-
财政年份:2000
-
负责人:MIZUTANI Shigehiko
-
依托单位:
physiological significance of placental aminopeptidases
-
批准号:02454378
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.48万
-
财政年份:1990
-
负责人:MIZUTANI Shigehiko
-
依托单位:
The etiology of pregnancy-induced hypertension based on the degradation of angiotensin II by placental aminopeptidases
-
批准号:61570787
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:1986
-
负责人:MIZUTANI Shigehiko
-
依托单位:
国内基金
海外基金
Oxytocin通过MAPK/ERK信号通路调控血管平滑肌细胞表型转换在颅内动脉瘤发生发展中的作用及相关分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:王刚
-
依托单位:
Oxytocin在社交响应及免疫调节中的协同作用及机制研究
-
批准号:81870949
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2018
-
负责人:景玉宏
-
依托单位: